Erratum: ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood-brain barrier cell line, hCMEC/D3 (Molecular Pharmaceutics (2010) 7:4 (1057-1068) DOI: 10.1021/mp900178j);ABC and SLC transporter expression and pot substrate characterization across the human CMEC/D3 blood-'brain barrier cell line

Molecular Pharmaceutics

Volumn 7, Issue 4, 2010, Pages 1057-1068

  Carl, Stephen M ^a,b   Lindley, David J ^a,c   Couraud, Pierre O ^c,e   Weksler, Babette B ^d   Romero, Ignacio ^f,g   Mowery, Stephanie A ^a   Knipp, Gregory T ^a  

^a PURDUE UNIVERSITY   (United States)

^b Unigene Laboratories Incorporated   (United States)

^c ABBOTT LABORATORIES   (United States)

^d INSTITUT COCHIN   (France)

^e INSERM   (France)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g OPEN UNIVERSITY   (United Kingdom)

Author keywords

ABC transporters; Blood brain barrier; hCMEC D3 cell line; peptide histidine transporter; SLC transporters

Indexed keywords

ABC TRANSPORTER; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; MANNITOL; MONOCARBOXYLATE TRANSPORTER 1; MONOCARBOXYLATE TRANSPORTER 4; MONOCARBOXYLATE TRANSPORTER 8; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; ORGANIC CATION TRANSPORTER 3; PEPTIDE TRANSPORTER 1; PEPTIDE TRANSPORTER 2; PROTON COUPLED OLIGOPEPTIDE TRANSPORTER; SLC TRANSPORTER; UNCLASSIFIED DRUG; UREA;

ARTICLE; BLOOD BRAIN BARRIER; CELL CULTURE; CELL LINE; DRUG PENETRATION; DRUG SCREENING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPORT KINETICS; UNINDEXED SEQUENCE;

EID: 77955243526     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300626k     Document Type: Erratum

References (36)

1. Liederer, B. M.; Phan, K. T.; Ouyang, H.; Borchardt, R. T. Significant differences in the disposition of cyclic prodrugs of opioid peptides in rats and guinea pigs following IV administration J. Pharm. Sci. 2005, 94 (12) 2676-2687
2. Hawkins, R. A.; O'Kane, R. L.; Simpson, I. A.; VinÌa, J. R. Structure of the blood-brain barrier and its role in the transport of amino acids J. Nutr. 2006, 136 (1 Suppl. 218S-'226S
3. Nicolazzo, J. A.; Charman, S. A.; Charman, W. N. Methods to assess drug permeability across the blood-brain barrier J. Pharm. Pharmacol. 2006, 58 (3) 281-293
4. Jeffrey, P.; Summerfield, S. G. Challenges for blood-brain barrier (BBB) screening Xenobiotica 2007, 37 (10-'11) 1135-1151
5. Weksler, B. B.; Subileau, E. A.; PerrieÌre, N.; Charneau, P.; Holloway, K.; Leveque, M.; Tricoire-Leignel, H.; Nicotra, A.; Bourdoulous, S.; Turowski, P.; Male, D. K.; Roux, F.; Greenwood, J.; Romero, I. A.; Couraud, P. O. Blood-brain barrier-specific properties of a human adult brain endothelial cell line FASEB J. 2005, 19 (13) 1872-1904
6. Poller, B.; Gutmann, H.; Krähenbühl, S.; Weksler, B.; Romero, I.; Couraud, P. O.; Tuffin, G.; Drewe, J.; Huwyler, J. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies J. Neurochem. 2008, 107 (5) 1358-1368
7. Dauchy, S.; Miller, F.; Couraud, P. O.; Weaver, R. J.; Weksler, B.; Romero, I. A.; Scherrmann, J. M.; De Waziers, I.; DecleÌves, X. Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells Biochem. Pharmacol. 2009, 77 (5) 897-909
8. Nicolazzo, J. A.; Katneni, K. Drug transport across the blood-brain barrier and the impact of breast cancer resistance protein (ABCG2) Curr. Top. Med. Chem. 2009, 9 (2) 130-147
9. Sorensen, M.; Steenberg, B.; Knipp, G. T.; Wang, W.; Steffansen, B.; Frokjaer, S.; Borchardt, R. T. The effect of beta-turn structure on the permeation of peptides across monolayers of bovine brain microvessel endothelial cells Pharm. Res. 1997, 14 (10) 1341-1348
10. Graul, R. C.; Sadée, W. Sequence alignments of the H(+)-dependent oligopeptide transporter family PTR: Inferences on structure and function of the intestinal PEPT1 transporter Pharm. Res. 1997, 14, 388,zlpg > 400
11. Nussberger, S.; Steel, A.; Hediger, M. Structure and pharmacology of proton-linked peptide transporters J. Controlled Release 1997, 46, 31-38
12. Yang, C. Y.; Dantzing, A. H.; Pidgeon, C. Intestinal peptide transport of systems and oral drug availability Pharm. Res. 1999, 16, 1331-1343
13. Meredith, D.; Boyd, C. A. R. Structure and function of eukaryotic peptide transporters Cell. Mol. Life Sci. 2000, 57, 754-778
14. Rubio-Aliaga, I.; Daniel, H. Mammalian peptide transporters as targets for drug delivery Trends Pharmacol. Sci. 2002, 23 (9) 434-440
15. Herrera-Ruiz, D.; Knipp, G. T. Current perspectives on established and putative mammalian oligopeptide transporters J. Pharm. Sci. 2003, 92 (4) 691-714
16. Carl, S. M.; Herrera-Ruiz, D.; Bhardwaj, R. K.; Gudmundsson, O.; Knipp, G. T. Mammalian Oligopeptide Transporters. In Drug Transporters: Molecular Characterization and Role in Drug Disposition; You, G.; Morris, M. E., Eds.; John Wiley & Sons, Inc.: Hoboken, NJ, 2007; pp 105 -' 145. ISBN: 978-0-471-78491-3.
17. Adson, A.; Burton, P. S.; Raub, T. J.; Barsuhn, C. L.; Audus, K. L.; Ho, N. F. Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers J. Pharm. Sci. 1995, 84 (10) 1197-1204
18. Knipp, G. T.; Ho, N. F.; Barsuhn, C. L.; Borchardt, R. T. Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size J. Pharm. Sci. 1997, 86 (10) 1105-1110
19. Steiner, E.; Holzmann, K.; Elbling, L.; Micksche, M.; Berger, W. Cellular functions of vaults and their involvement in multidrug resistance Curr. Drug Targets 2006, 7 (8) 923-934
20. Berger, U. V.; Hediger, M. A. Distribution of peptide transporter PEPT2 mRNA in the rat nervous system Anat. Embryol. 1999, 199 (5) 439-449
21. Smith, D. E.; Johanson, C. E.; Keep, R. F. Peptide and peptide analog transport systems at the blood-CSF barrier Adv. Drug Delivery Rev. 2004, 56 (12) 1765-1791
22. Bhardwaj, R. K.; Herrera-Ruiz, D. R.; Xu, Y.; Carl, S. M.; Cook, T. J.; Vorsa, N.; Knipp, G. T. Drug Transporters and Absorption. In Biopharmaceutics Applications in Drug Development; Krishna, R.; Yu, U.; Skelly, J.; Agarwal, V., Eds.; Kluwer Press: pp 175 -' 261.
23. Cansev, M. Uridine and cytidine in the brain: their transport and utilization Brain Res. Rev. 2006, 52 (2) 389-397
24. Chikhale, E. G.; Ng, K. Y.; Burton, P. S.; Borchardt, R. T. Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides Pharm. Res. 1994, 11 (3) 412-419
25. Chen, W.; Yang, J. Z.; Andersen, R.; Nielsen, L. H.; Borchardt, R. T. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs across the blood-brain barrier using an in situ perfused rat brain model J. Pharmacol. Exp. Ther. 2002, 303 (2) 849-857
26. Reichel, A. The role of blood-brain barrier studies in the pharmaceutical industry Curr. Drug Metab. 2006, 7 (2) 183-203
27. Shaftel, S. S.; Carlson, T. J.; Olschowka, J. A.; Kyrkanides, S.; Matousek, S. B.; O'Banion, M. K. Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration J. Neurosci. 2007, 27 (35) 9301-9309
28. Cucullo, L.; Couraud, P. O.; Weksler, B.; Romero, I. A.; Hossain, M.; Rapp, E.; Janigro, D. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies J. Cereb. Blood Flow Metab. 2008, 28 (2) 312-328
29. Förster, C.; Burek, M.; Romero, I. A.; Weksler, B.; Couraud, P.-O.; Drenckhahn, D. Differential effects of hydrocortisone and TNF{alpha} on tight junction proteins in an in vitro model of the human blood-brain barrier J. Physiol. 2008, 586 (7) 1937-1949
30. Poller, B.; Gutmann, H.; Krähenbühl, S.; Weksler, B.; Romero, I.; Couraud, P. O.; Tuffin, G.; Drewe, J.; Huwyler, J. The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies J. Neurochem. 2008, 107 (5) 1358-1368
31. Renkin, E. M. Filtration, diffusion and molecular sieving through porous cellulose membranes J. Gen. Physiol. 1954, 38 (2) 225-243
32. Seki, T.; Kanbayashi, H.; Nagao, T.; Chono, S.; Tabata, Y.; Morimoto, K. Effect of cationized gelatins on the paracellular transport of drugs through caco-2 cell monolayers J. Pharm. Sci. 2006, 95 (6) 1393-1401
33. Fenstermacher, J. D.; Johnson, J. A. Filtration and reflection coefficients of the rabbit blood-brain barrier Am. J. Physiol. 1966, 211 (2) 341-346
34. Knipp, G. T.; Vander Velde, D. G.; Siahaan, T. J.; Borchardt, R. T. The effect of beta-turn structure on the passive diffusion of peptides across Caco-2 cell monolayers Pharm. Res. 1997, 14 (10) 1332-1340
35. Kuchibhotla, K. V.; Lattarulo, C. R.; Hyman, B. T.; Bacskai, B. J. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice Science 2009, 323 (5918) 1211-1215
36. Bhardwaj, R. K.; Herrera-Ruiz, D. R.; Eltoukhy, N.; Saad, M.; Knipp, G. T. The Functional Evaluation of Human Peptide/Histidine Transporter 1 (HPHT1) in Transiently Transfected COS-7 Cells Eur. J. Pharm. Sci. 2006, 27, 533-542